Featured Editorial
-
ICH M4Q(R2) And M16 Modernize The CTD For Digital Submissions
9/28/2026
A former FDA assessor explains how recent changes to the common technical document bring long-overdue updates to the submission process, accounting for greater data demands.
-
Prioritizing Quality Over Everything
9/28/2026
Regulatory compliance and cGMP manufacturing expert Tatyana Matveeva, Ph.D., explains the role and importance of a quality unit in an organization, as well as what happens when it’s compromised.
-
Building Sustainable Biopharma Supply Chains Starts With Procurement
9/24/2026
Nearly all the industry's emissions happen upstream from core manufacturing functions. This puts sustainability almost entirely on the shoulders of purchasing.
-
Engineering Better ADCs, Part 1: MoA, Conjugation Chemistry, And More
9/24/2026
The field has evolved considerably in antibody–drug conjugate (ADC) science. In this first article of a two-part series, let's discuss how to engineer better ADCs, covering MoA, conjugation chemistry, and more.
-
Sustainable Facility Design Brings Bayer Instant Savings
9/23/2026
ROI for sustainability initiatives often come later as lower maintenance and utility costs. Bayer's pursuit of LEED certification led to substantial savings up front.
-
Why You Should Measure Comparability Debt Before Ever Starting A Study
9/17/2026
When analytical capability and process understanding fail to keep pace with a drug candidate, the technical uncertainty creates debt that's difficult to pay down.
-
What FDA Inspectors Want From Your OOS File
9/16/2026
Read enough FDA warning letters and a pattern emerges: Investigators rarely cite a retest that was performed badly. They cite a retest that nobody justified in writing. Let's take a closer look.
-
You Can't CAPA What You Can't Classify
9/16/2026
An LLM or agentic error can occur with no component broken in any way the QMS recognizes. Classifying it takes two fields: the error type and the error origination point.
-
New USP Guidelines, Standards Address Lentivirus Characterization
9/16/2026
The United States Pharmacopeia is rolling out new standards and tools to help manufacturers characterize fragile, complex lentiviral vectors.
-
6 Modeling Approaches That Make Complex Bioprocess Data Useful
9/14/2026
AI algorithms can reduce data dimensionality more faithfully by interpreting multivariate features relevant to prediction or control.